Latest Breaking News On - Amplatzer piccolo occluder - Page 7 : comparemela.com
Abbott launches pea-sized life-saving device for babies with hole in heart
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Abbott launches new device in India for treatment of premature babies, newborns with heart openings
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Abbott India launches device to treat congenital heart defects in premature babies
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Abbott s HeartMate 3 VAD for Pediatric Patients
HeartMate 3 heart pump approved for use for pediatric patients battling advanced heart failure offering a new treatment option for this underserved population
December 21, 2020 U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott s HeartMate 3left ventricular assist device (LVAD) to be used in pediatric patients with advanced refractory left ventricular heart failure. With the updated labeling, physicians now have additional options for treating this underserved population awaiting a heart transplant or for those not eligible to receive a transplant as a result of potential complications or risk related to the procedure.
FDA Approves Labeling Update for Abbott s HeartMate 3 Heart Pump for use in Pediatric Patients
- Abbott s HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure
- This life-saving technology provides new treatment option for underserved population
News provided by
Share this article
Share this article
ABBOTT PARK, Ill., Dec. 17, 2020 /PRNewswire/ Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company s HeartMate 3™ heart pump to be used in pediatric patients with advanced refractory left ventricular heart failure. With the updated labeling, physicians now have additional options for treating this underserved population awaiting a heart transplant or for those not eligible to receive a transplant as a result of potential complications or risk related to the procedure.